Loading clinical trials...

Wireless Irradiance SEnsors During Neonatal Phototherapy | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

Wireless Irradiance SEnsors During Neonatal Phototherapy

Wireless Irradiance SEnsors During Neonatal Phototherapy: The WISE Clinical Study

NCT07057635•McGill University Health Centre/Research Institute of the McGill University Health Centre

Summary

Bilisensors are devices designed to measure the cumulative dose of phototherapy administered to neonates undergoing treatment for hyperbilirubinemia. The current standard of care typically involves intermittent spot measurements once a day using a handheld dosimeter that may give variable estimations. In contrast, bilisensors may enable continuous, real-time monitoring of light exposure, helping to know the total phototherapy dose received by the infant.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participants must be admitted to the Montreal Children's Hospital (MCH) Neonatal Intensive Care Unit (NICU)
•Under phototherapy as clinically indicated
•Diagnosis of indirect hyperbilirubinemia
•Weight of \>1000g at time of enrollment

Exclusion Criteria

•Any abnormal skin conditions (example: extreme dryness, desquamation, congenital skin disorders, etc.)
•Diagnosis of direct hyperbilirubinemia
•Weight of \<1000g at time of enrollment
•Any baby or family deemed ineligible (ex. too much stress, too unstable) by the clinical care team

Key Dates

Start Date

July 10, 2025

Primary Completion Date

September 10, 2025

Completion Date

September 10, 2025

Last Updated

July 10, 2025

Enrollment

ESTIMATED participants

Conditions

Neonatal HyperbilirubinemiaJaundice, NeonatalPhototherapy ComplicationNewborn Complication

Contacts

Alyssa Maximov, BSc

CONTACT

5149341934 alyssa.maximov@muhc.mcgill.ca

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

NCT06517862

Neonatal Hyperbilirubinemia

View study

RECRUITINGNA

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

NCT07346976

Neonatal Hyperbilirubinemia

View study

ACTIVE_NOT_RECRUITING

Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 10, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Wireless Irradiance SEnsors During Neonatal Phototherapy

Inclusion Criteria

Exclusion Criteria

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Transcutaneous Bilirubinometry and Phototherapy

The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy

Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy